Results 31 to 40 of about 6,006,073 (362)

Protein-protein interaction modulator drug discovery [PDF]

open access: yes, 2022
S.1393-1404Introduction: Historically, small-molecule drug discovery projects have largely focused on the G-protein-coupled receptor, ion-channel and enzyme target classes.
Hadian, K., Gul, S.
core   +1 more source

An engineered tetra-valent antibody fully activates the Tie2 receptor with comparable potency to its natural ligand angiopoietin-1

open access: yesScientific Reports, 2021
Activation of the tyrosine kinase with Ig and epidermal growth factor homology domain 2 (Tie2) receptor by angiopoietin-1 (Ang1) is critical for vascular stabilization: it promotes survival signal transduction via auto-phosphorylation and reduces ...
Yukari Koya   +4 more
doaj   +1 more source

Antimalarial drug discovery: progress and approaches

open access: yesNature reviews. Drug discovery, 2023
Recent antimalarial drug discovery has been a race to produce new medicines that overcome emerging drug resistance, whilst considering safety and improving dosing convenience.
Jair L. Siqueira-Neto   +5 more
semanticscholar   +1 more source

Functional pharmacology: the drug discovery bottleneck? [PDF]

open access: yes, 2004
It is our contention that functional pharmacology, particularly in vivo, must play a greater role in drug discovery if the promises of reductionist techniques are to be brought to full fruition.

core   +1 more source

Drug discovery and development: introduction to the general public and patient groups

open access: yesFrontiers in Drug Discovery, 2023
Finding new drugs usually consists of five main stages: 1) a pre-discovery stage in which basic research is performed to try to understand the mechanisms leading to diseases and propose possible targets (e.g., proteins); 2) the drug discovery stage ...
Natesh Singh   +5 more
semanticscholar   +1 more source

Discovery of Antiepileptic Drugs [PDF]

open access: yesNeurotherapeutics, 2007
Since 1993, the Anticonvulsant Drug Development Program has contributed to the successful development of nine clinically effective drugs for the symptomatic treatment of epilepsy. These include felbamate (1993), gabapentin (1994), lamotrigine (1994), fosphenytoin (1996), topiramate (1996), tiagabine (1997), levetiracetam (1999), zonisamide (2000), and ...
Misty, Smith   +2 more
openaire   +2 more sources

Cancer drug discovery: recent innovative approaches to tumor modeling [PDF]

open access: yes, 2016
Introduction: Cell culture models have been at the heart of anti-cancer drug discovery programs for over half a century. Advancements in cell culture techniques have seen the rapid evolution of more complex in vitro cell culture models investigated for ...
Avery, Vicky   +5 more
core   +1 more source

Photochemistry in Flow for Drug Discovery [PDF]

open access: yes, 2021
S.71-119The discovery of new drug candidates and the development of new lead structures for future active pharmaceutical ingredients are continuous processes, which combine the expertise of many scientific disciplines.
Rehm, Thomas H., Thomas H. Rehm
core   +1 more source

Angiopoietin-2 impairs collateral artery growth associated with the suppression of the infiltration of macrophages in mouse hindlimb ischaemia

open access: yesJournal of Translational Medicine, 2016
Background Angiopoietin-2 (Ang-2), a ligand of the Tie-2 receptor, plays an important role in maintaining endothelial cells and in destabilizing blood vessels. Collateral artery growth (arteriogenesis) is a key adaptive response to arterial occlusion. It
Xiaoyong Tan   +11 more
doaj   +1 more source

Fibronectin extra domain A as a drug delivery targeting epitope for rheumatoid arthritis

open access: yesAdvances in Rheumatology, 2022
Objectives To assess the ability of monoclonal antibodies (mAbs) specific for fibronectin extra-domain A (FnEDA) to target diseased tissues of mouse collagen induced arthritis (mCIA) models.
Victor Z. Sun   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy